ESR1 and breast cancer: Furthermore, Somers-Edgar et al. had shown that a combination of EGCG (25 μM) and curcumin (3 μM) is synergistically cytotoxic toward MDA-MB-231 human breast cancer cells in vitro and decreases ERα-tumor growing in vivo [54].